ClinicalTrials.govpublic full text
A Non-interventional, Post-Marketing Study to Describe Outcome of Nitisinone Treatment in HT-1 Patients
hereditary tyrosinemia, type i, rare diseases, fumarylacetoacetate hydrolase (fah) deficiency, liver failure, drug treatment, nitisinone, observational research, phase iv, china, pediatric patient, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 895906
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.